Health
Biotech Executive's Success and Upcoming Trial Results
Greg Verdine, a scientist-turned-biotech executive, is experiencing significant success. Tenax Therapeutics will soon report results from a major Phase 3 study of a heart failure treatment, which could have substantial implications for the biotech sector.
Coverage timeline — 2 articles
STAT News
Scientist-turned-biotech executive Greg Verdine is having a very good year.
2026-08-06 10:30 UTC
STAT News
Tenax Therapeutics will soon report results from a Phase 3 study that is one of the biggest binary biotech stock events remaining in the sector this year.
2026-08-06 10:30 UTC